ClinicalTrials.Veeva

Menu

PPI Versus Placebo in Severe Functional Heartburn

University of Southern California logo

University of Southern California

Status

Withdrawn

Conditions

GERD

Treatments

Drug: PPI

Study type

Interventional

Funder types

Other

Identifiers

NCT00222989
#026020
474200

Details and patient eligibility

About

Proton Pump Inhibitors are no better than placebo in relieving GERD symptoms in patients with functional Heartburn.

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Heartburn twice a week for at least 2 years. Normal EGD and 24hr pH study.

Exclusion criteria

  • <18yrs of age,pregnant, unable or unwilling to give consent, allergic to PPI, previous gastric or esophageal surgery, past hx of erosive GERD, unwilling or unable to stop acid suppression meds

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Double Blind

0 participants in 1 patient group

no label study
Other group
Description:
1
Treatment:
Drug: PPI

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems